VERU Stock Summary and Trading Ideas (Veru | NASDAQ:VERU)

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Veru trades on the NASDAQ stock market under the symbol VERU.

As of February 27, 2026, VERU stock price declined to $2.58 with 28,792 million shares trading.

VERU has a beta of -0.04, meaning it tends to be less sensitive to market movements. VERU has a correlation of 0.00 to the broad based SPY ETF.

VERU has a market cap of $41.41 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, VERU traded as high as $40.80 and as low as $2.10.

The top ETF exchange traded funds that VERU belongs to (by Net Assets): VTI, VXF.

VERU has underperformed the market in the last year with a return of -50.0%, while SPY returned +18.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VERU shares. However, VERU has outperformed the market in the last 3 month and 2 week periods, returning +5.7% and +12.7%, while SPY returned +1.2% and +0.6%, respectively. This indicates VERU has been having a stronger performance recently.

VERU support price is $2.51 and resistance is $2.81 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VERU shares will trade within this expected range on the day.